CLC number: R733.7
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 2015-06-16
Cited: 4
Clicked: 5296
Bo Wang, Sheng-yun Lin, Ying-ying Shen, Li-qiang Wu, Zhen-zhen Chen, Jing Li, Zhi Chen, Wen-bin Qian, Jian-ping Jiang. Pure total flavonoids from Citrus paradisi Macfadyen act synergistically with arsenic trioxide in inducing apoptosis of Kasumi-1 leukemia cells in vitro[J]. Journal of Zhejiang University Science B, 2015, 16(7): 580-585.
@article{title="Pure total flavonoids from Citrus paradisi Macfadyen act synergistically with arsenic trioxide in inducing apoptosis of Kasumi-1 leukemia cells in vitro",
author="Bo Wang, Sheng-yun Lin, Ying-ying Shen, Li-qiang Wu, Zhen-zhen Chen, Jing Li, Zhi Chen, Wen-bin Qian, Jian-ping Jiang",
journal="Journal of Zhejiang University Science B",
volume="16",
number="7",
pages="580-585",
year="2015",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1400234"
}
%0 Journal Article
%T Pure total flavonoids from Citrus paradisi Macfadyen act synergistically with arsenic trioxide in inducing apoptosis of Kasumi-1 leukemia cells in vitro
%A Bo Wang
%A Sheng-yun Lin
%A Ying-ying Shen
%A Li-qiang Wu
%A Zhen-zhen Chen
%A Jing Li
%A Zhi Chen
%A Wen-bin Qian
%A Jian-ping Jiang
%J Journal of Zhejiang University SCIENCE B
%V 16
%N 7
%P 580-585
%@ 1673-1581
%D 2015
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1400234
TY - JOUR
T1 - Pure total flavonoids from Citrus paradisi Macfadyen act synergistically with arsenic trioxide in inducing apoptosis of Kasumi-1 leukemia cells in vitro
A1 - Bo Wang
A1 - Sheng-yun Lin
A1 - Ying-ying Shen
A1 - Li-qiang Wu
A1 - Zhen-zhen Chen
A1 - Jing Li
A1 - Zhi Chen
A1 - Wen-bin Qian
A1 - Jian-ping Jiang
J0 - Journal of Zhejiang University Science B
VL - 16
IS - 7
SP - 580
EP - 585
%@ 1673-1581
Y1 - 2015
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1400234
Abstract: To investigate the potential effects of pure total flavonoid compounds (PTFCs) from Citrus paradisi Macfadyen separately or combined with arsenic trioxide on the proliferation of human myeloid leukemia cells and the mechanisms underlying the action of PTFCs. The effects of PTFCs separately or combined with arsenic trioxide on the proliferation and apoptosis of leukemia cells were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), fluorescence microscopy, and flow cytometry. Their effects on the expression levels of apoptosis-related regulators were determined by Western blot assay. PTFCs combined with arsenic trioxide significantly inhibited the growth of Kasumi-1 cells, and apoptosis was confirmed by flow cytometry analysis. Hoechst 33258 staining showed more significant morphological changes and more apoptosis following the combined treatment. Western blots showed changes in the expression of genes for poly ADP-ribose polymerase (PARP), caspase 3/9, and P65. The results indicated that PTFCs separately or combined with arsenic trioxide inhibited proliferation of leukemia cells in vitro and induced their apoptosis by modulating the expression of apoptosis-related regulator genes.
[1]Balcerczak, E., Bartkowiak, J., Blonski, J.Z., et al., 2002. Expression of gene encoding P65 oncofetal protein in acute and chronie leukemias. NeoPlasma, 49(5):295-299.
[2]Bueso-Ramos, C.E., Rocha, F.C., Shishodia, S., et al., 2004. Expression of constitutively active nuclear-κB RelA transcription factor in blasts of acute myeloid leukemia. Hum. Pathol., 35(2):246-253.
[3]Crowder, R.N., El-Deiry, W.S., 2012. Caspase-8 regulation of TRAIL-mediated cell death. Exp. Oncol., 34(3):160-164.
[4]Ghosh, S., May, M.J., Kopp, E.B., 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol., 16:225-260.
[5]Girennavar, B., Jayaprakasha, G.K., Jifon, J.L., et al., 2008. Variation of bioactive furocoumarins and flavonoids in different varieties of grapefruits and pummelo. Eur. Food Res. Technol., 226(6):1269-1275.
[6]Goldman, J.M., Melo, J.V., 2003. Chronic myeloid leukemia—advances in biology and new approaches to treatment. N. Engl. J. Med., 349(15):1451-1464.
[7]Guzman, M.L., Neering, S.J., Upchurch, D., et al., 2001. Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood, 98(8):2301-2307.
[8]Hatta, Y., Arima, N., Machino, T., et al., 2003. Mutation analysis of IκBα in hematologic malignancies. Int. J. Mol. Med., 11(2):239-242.
[9]Havsteen, B.H., 2002. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther., 96(2-3):67-202.
[10]Krause, D.S., Crispino, J.D., 2013. Molecular pathways: induction of polyploidy as a novel differentiation therapy for leukemia. Clin. Cancer Res., 19(22):6084-6088.
[11]Leung, H.W., Yang, W.H., Lai, M.Y., et al., 2007. Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem. Toxicol., 45(3):403-411.
[12]Mathews, W., Paul, M.V., Abhilash, M., et al., 2013. Myocardial toxicity of acute promyelocytic leukaemia drug-arsenic trioxide. Eur. Rev. Med. Pharmacol. Sci., 17(1):34-38.
[13]Middleton, E.Jr., Kandaswami, C., Theoharides, T.C., 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 52(4):673-751.
[14]Ni, H., Ergin, M., Huang, Q., et al., 2001. Analysis of expression of nuclear factor κB (NF-κB) in multiple myeloma: downregulation of NF-κB induces apoptosis. Br. J. Haematol., 115(2):279-286.
[15]Pan, M.H., Lai, C.S., Hsu, P.C., et al., 2005. A cacetin induces apoptosis in human gastric carcinoma cells accompanied by activation of caspase cascadesand production of reactive oxygen species. J. Agric. Food Chem., 53(3):620-630.
[16]Parekh, H.S., Liu, G., Wei, M.Q., 2009. A new dawn for the use of traditional Chinese medicine in cancer therapy. Mol. Cancer, 8:21.
[17]Patil, B.S., Jayaprakasha, G.K., Chidambara Murthy, K.N., et al., 2009. Bioactive compounds: historical perspectives, opportunities, and challenges. J. Agric. Food Chem., 57(18):8142-8160.
[18]Piccaluga, P.P., Martinelli, G., Baccarani, M., 2006. Advances in the treatment for haematological malignancies. Expert Opin. Pharmacother., 7(6):721-732.
[19]Ranelletti, F.O., Maqqiano, N., Serra, F.G., et al., 2000. Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumors. Int. J. Cancer, 85(3):438-445.
[20]Salucci, M., Stivala, L.A., Maiani, G., et al., 2002. Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2). Br. J. Cancer, 86(10):1645-1651.
[21]Schlenk, R.F., Dohner, K., Krauter, J., et al., 2008. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med., 358(18):1909-1918.
[22]Yu, L.L., Yu, H.G., Yu, J.P., et al., 2004. Nuclear factor-κB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinomatissue. World J. Gastroenterol., 10(22):3255-3260.
Open peer comments: Debate/Discuss/Question/Opinion
<1>